APA aipamena

Cork, M., Thaçi, D., Eichenfield, L., Arkwright, P., Hultsch, T., Davis, J., . . . Bansal, A. (2019). Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: Results from a phase IIa open‐label trial and subsequent phase III open‐label extension. Br J Dermatol.

Chicago Style aipamena

Cork, M.J., et al. "Dupilumab in Adolescents With Uncontrolled Moderate‐to‐severe Atopic Dermatitis: Results From a Phase IIa Open‐label Trial and Subsequent Phase III Open‐label Extension." Br J Dermatol 2019.

MLA aipamena

Cork, M.J., et al. "Dupilumab in Adolescents With Uncontrolled Moderate‐to‐severe Atopic Dermatitis: Results From a Phase IIa Open‐label Trial and Subsequent Phase III Open‐label Extension." Br J Dermatol 2019.